Nothing Special   »   [go: up one dir, main page]

MXPA03001826A - Derivados de arilpiperazina. - Google Patents

Derivados de arilpiperazina.

Info

Publication number
MXPA03001826A
MXPA03001826A MXPA03001826A MXPA03001826A MXPA03001826A MX PA03001826 A MXPA03001826 A MX PA03001826A MX PA03001826 A MXPA03001826 A MX PA03001826A MX PA03001826 A MXPA03001826 A MX PA03001826A MX PA03001826 A MXPA03001826 A MX PA03001826A
Authority
MX
Mexico
Prior art keywords
psychotropic agents
arylpiperazine derivatives
arylpiperazine
derivatives
psychotropic
Prior art date
Application number
MXPA03001826A
Other languages
English (en)
Inventor
Gerd Bartoszyk
Original Assignee
Merck Patent Gsesellschaft Mit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gsesellschaft Mit filed Critical Merck Patent Gsesellschaft Mit
Publication of MXPA03001826A publication Critical patent/MXPA03001826A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03001826A 2000-09-05 2001-08-07 Derivados de arilpiperazina. MXPA03001826A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10043659A DE10043659A1 (de) 2000-09-05 2000-09-05 Arylpiperazinderivate
PCT/EP2001/009108 WO2002020491A1 (de) 2000-09-05 2001-08-07 Arylpiperazinderivate und deren verwendung als psychopharmaka

Publications (1)

Publication Number Publication Date
MXPA03001826A true MXPA03001826A (es) 2003-06-04

Family

ID=7655009

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001826A MXPA03001826A (es) 2000-09-05 2001-08-07 Derivados de arilpiperazina.

Country Status (15)

Country Link
US (1) US20040014972A1 (es)
EP (1) EP1326842A1 (es)
KR (1) KR20030024913A (es)
CN (1) CN1452614A (es)
AU (1) AU2001291744A1 (es)
BR (1) BR0113581A (es)
CA (1) CA2421219A1 (es)
CZ (1) CZ2003809A3 (es)
DE (1) DE10043659A1 (es)
MX (1) MXPA03001826A (es)
NO (1) NO20030998D0 (es)
PL (1) PL360289A1 (es)
SK (1) SK3612003A3 (es)
WO (1) WO2002020491A1 (es)
ZA (1) ZA200302636B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60231507D1 (de) 2001-07-20 2010-07-01 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
WO2004082570A2 (en) * 2003-03-17 2004-09-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dopamine receptor d2 (drd2)
CA2531980C (en) 2003-06-23 2013-09-17 Dainippon Sumitomo Pharma Co., Ltd. Imide derivatives as therapeutic agents for senile dementia
ES2250000B1 (es) * 2004-09-29 2007-06-01 Medichem, S.A. Procedimiento para la preparacion de ziprasidona.
ES2250001B1 (es) * 2004-09-29 2007-06-01 Medichem, S.A. Proceso para la purificacion de ziprasidona.
KR100660142B1 (ko) * 2005-01-24 2006-12-20 이명섭 건식 모래 생산 방법 및 그 시스템
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
TW200800959A (en) * 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
TW200808730A (en) * 2006-06-09 2008-02-16 Wyeth Corp Process for synthesizing piperazine-piperidine compounds
AR063984A1 (es) * 2006-11-28 2009-03-04 Wyeth Corp Metabolitos de 5-fluoro-8-{4-[4-(6-metoxiquinolin-8-il)piperazin-1-il]piperidin-1-il}quinolina, metodos de preparacion, su uso en la fabricacion de medicamentos para el tratamiento de trastornos relacionados con 5-ht1a, composicion farmaceutica que los comprende, compuestos radioetiquetados derivado
MX2009009873A (es) 2007-03-15 2009-09-24 Novartis Ag Compuestos organicos y sus usos.
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
JP3185222B2 (ja) * 1997-01-21 2001-07-09 ウェルファイド株式会社 チオフェン化合物およびその医薬用途
ES2128266B1 (es) * 1997-07-08 2000-01-16 Vita Invest Sa Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes.
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists

Also Published As

Publication number Publication date
EP1326842A1 (de) 2003-07-16
CA2421219A1 (en) 2003-03-03
PL360289A1 (en) 2004-09-06
SK3612003A3 (en) 2003-07-01
CN1452614A (zh) 2003-10-29
DE10043659A1 (de) 2002-03-14
BR0113581A (pt) 2003-07-15
WO2002020491A1 (de) 2002-03-14
CZ2003809A3 (cs) 2003-06-18
NO20030998L (no) 2003-03-04
AU2001291744A1 (en) 2002-03-22
KR20030024913A (ko) 2003-03-26
ZA200302636B (en) 2004-09-08
US20040014972A1 (en) 2004-01-22
NO20030998D0 (no) 2003-03-04

Similar Documents

Publication Publication Date Title
ZA200205557B (en) 4-Aminopicolinates and their use as herbicides.
HK1047743A1 (en) New use and novel n-azabicyclo-amide derivatives.
HUP0300268A3 (en) Herbicidal benzoylpyrazole derivatives, compositions containing the same and their use
HUP0301146A3 (en) 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
IL155071A0 (en) Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
MXPA03004644A (es) Derivados de fenilacetamdia-pirazol y su uso como agentes antitumorales.
HK1053118A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof.
MXPA02010914A (es) Amidas de antranilo y su uso como medicamentos.
EE200200414A (et) Dihüdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis
HUP0101333A2 (hu) Diazepánszármazékok és sóik, ezeket tartalmazó gyógyászati készítmények
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
IL155520A0 (en) Benzoxazinone derivatives, their preparation and use
HUP0303291A3 (en) Herbicidal composition, preparation and use thereof
ZA200204814B (en) Substituted phenyl-piperazine derivatives, their preparation and use.
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
MXPA03000644A (es) Nuevos derivados de indol y uso como medicamentos.
MXPA03001826A (es) Derivados de arilpiperazina.
HUP0303369A3 (en) Herbicidal composition, preparation and use thereof
EP1210084A4 (en) PYRIDOMORPHINANS, THIENOMORPHINANS AND THEIR USE
EG23929A (en) Isoxazolines derivatives and their use as antidepressants
MXPA03001557A (es) Derivados bifenilo.